We are live on
!
Find out more
MATN
Mateon Therapeutics, Inc.
MATN
MATN
Delisted
MATN was delisted on the 7th of December, 2016.
21 hedge funds and large institutions have $1.42M invested in Mateon Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
9% less capital invested
Capital invested by funds: $1.57M → $1.42M (-$147K)
13% less funds holding
Funds holding: 24 → 21 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
7
Reduced
3
Closed
3
Calls
–
Puts
$13K
Net Calls
-$13K
Net Calls Change
-$7K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$33.3K |
| 2 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$23.7K |
| 3 |
Goldman Sachs
New York
|
+$9.62K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.33K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.34K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14K |
| 2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$10K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.39K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$2.42K |
